Management of status epilepticus

Joseph I. Sirven, Elizabeth Waterhouse

Research output: Contribution to journalArticle

48 Scopus citations

Abstract

Status epilepticus is an increasingly recognized public health problem in the United States. Status epilepticus is associated with a high mortality rate that is largely contingent on the duration of the condition before initial treatment, the etiology of the condition, and the age of the patient. Treatment is evolving as new medications become available. Three new preparations - fos-phenytoin, rectal diazepam, and parenteral valproate - have implications for the management of status epilepticus. However, randomized controlled trials show that benzodiazepines (in particular, diazepam and lorazepam) should be the initial drug therapy in patients with status epilepticus. Despite the paucity of clinical trials comparing medication regimens for acute seizures, there is broad consensus that immediate diagnosis and treatment are necessary to reduce the morbidity and mortality of this condition. Moreover, investigators have reported that status epilepticus often is not considered in patients with altered consciousness in the intensive care setting. In patients with persistent alteration of consciousness for which there is no clear etiology, physicians should be more quickly prepared to obtain electroencephalography to identify status epilepticus. Physicians should rely on a standardized protocol for management of status epilepticus to improve care for this neurologic emergency.

Original languageEnglish (US)
Pages (from-to)469-476
Number of pages8
JournalAmerican Family Physician
Volume68
Issue number3
StatePublished - Aug 1 2003

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sirven, J. I., & Waterhouse, E. (2003). Management of status epilepticus. American Family Physician, 68(3), 469-476.